About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Cipla Unveils Generic Version of Oral Hepatitis C Drug in India

by Reshma Anand on December 22, 2015 at 11:39 AM
Font : A-A+

Cipla Unveils Generic Version of Oral Hepatitis C Drug in India

Indian drug maker, Cipla has announced that it has released the generic version of Hepatitis C drug, Sofosbuvir in India.

The drug will be marketed under the brand name 'Hepcvir-L' costing Rs 25,000 for a bottle of 28 tablets in India.

Advertisement


The company's product is a generic version of the drug maker Gilead Sciences Inc's Harvoni tablets. Gilead had decided to licence the manufacturing right of the medicine to generic companies to make it accessible in low-income countries soon after its launch in the US.

Hepcvir-L is the first once-a-day, fixed dose oral combination therapy that has been approved for chronic hepatitis C genotype 1 patients.

Managing Director and Global Chief Executive Officer Subhanu Saxena said, "The launch of Ledipasvir-Sofosbuvir is a further step to facilitate the optimal treatment for patients suffering from genotype 1 hepatitis C virus."

Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test  Your Knowledge on Heart
Test Your Knowlege on Genes
Obesity in Teens Make Inroads into Early Atrial Fibrillation
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Hepatitis A Hepatitis B Vasculitis Signature Drug Toxicity Silent Killer Diseases Liver Aplastic Anemia Hepatitis C Dental Check-Up 

Most Popular on Medindia

Iron Intake Calculator Calculate Ideal Weight for Infants Accident and Trauma Care A-Z Drug Brands in India Noscaphene (Noscapine) Find a Doctor Drug - Food Interactions Hearing Loss Calculator Indian Medical Journals Vent Forte (Theophylline)
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Cipla Unveils Generic Version of Oral Hepatitis C Drug in India Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests